Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Herpes simplex virus (HSV) is a common, highly contagious virus that infects humans and causes painful blisters or ulcers, most frequently on the mouth (oral herpes) or genitals (genital herpes). Once acquired, HSV remains in the body for life, establishing latency in nerve cells and periodically reactivating to cause recurrent symptoms. There are two main types of HSV: HSV-1, primarily causes oral herpes but can also cause genital infections, and HSV-2, primarily responsible for genital herpes but can also infect the oral region. Transmission occurs through direct skin-to-skin contact with infected mucous membranes, saliva, or fluid from sores.
Inhibition of viral DNA polymerase
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Herpes Simplex Virus (HSV).